Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001437749-24-038128·Bhat Laxminarayan
Schedule 13D ownership disclosure
REVIVA PHARMACEUTCLS HLDGS I
Common Stock, par value $0.0001 per share · CUSIP: 76152G100
Event date: 2024-12-18
- Filing-level shares
- 3,198,242.00
- Percent of class
- 6.8%
- Bhat LaxminarayanReported CIK 0001818245
Shares: 3,198,242.00 · Class: 6.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001437749-24-038128
- Form type
- SCHEDULE 13D/A
- Filer
- Bhat Laxminarayan
- CIK
- CIK 1818245
- Filed
- Dec 20, 2024
- Reporting period
- Dec 18, 2024
- Description
- Schedule 13D beneficial ownership